Macquarie Group’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-47,900
| Closed | -$3.57M | – | 1640 |
|
|
2025
Q2 | $3.57M | Sell |
47,900
-582
| -1% | -$38.5K | ﹤0.01% | 1058 |
|
|
2025
Q1 | $3.08M | Buy |
48,482
+3,147
| +7% | +$214K | ﹤0.01% | 1100 |
|
|
2024
Q4 | $3.54M | Sell |
45,335
-585
| -1% | -$47K | ﹤0.01% | 1027 |
|
|
2024
Q3 | $3.69M | Buy |
45,920
+4,396
| +11% | +$355K | ﹤0.01% | 1043 |
|
|
2024
Q2 | $3.44M | Sell |
41,524
-3,428
| -8% | -$302K | ﹤0.01% | 1067 |
|
|
2024
Q1 | $3.84M | Buy |
44,952
+6,927
| +18% | +$544K | ﹤0.01% | 1037 |
|
|
2023
Q4 | $3.25M | Buy |
38,025
+5,530
| +17% | +$478K | ﹤0.01% | 1082 |
|
|
2023
Q3 | $2.91M | Buy |
32,495
+634
| +2% | +$56.6K | ﹤0.01% | 1063 |
|
|
2023
Q2 | $2.71M | Buy |
31,861
+1,887
| +6% | +$160K | ﹤0.01% | 1085 |
|
|
2023
Q1 | $2.48M | Buy |
29,974
+2,226
| +8% | +$180K | ﹤0.01% | 1103 |
|
|
2022
Q4 | $2.18M | Sell |
27,748
-12,852
| -32% | -$1.03M | ﹤0.01% | 1180 |
|
|
2022
Q3 | $3.04M | Sell |
40,600
-5,418
| -12% | -$389K | ﹤0.01% | 1107 |
|
|
2022
Q2 | $3M | Buy |
46,018
+51
| +0.1% | +$3.02K | ﹤0.01% | 1161 |
|
|
2022
Q1 | $2.91K | Buy |
45,967
+1,412
| +3% | +$76.8K | ﹤0.01% | 1269 |
|
|
2021
Q4 | $2.36M | Buy |
44,555
+1,039
| +2% | +$63.3K | ﹤0.01% | 1325 |
|
|
2021
Q3 | $3.07M | Buy |
43,516
+5,071
| +13% | +$320K | ﹤0.01% | 1242 |
|
|
2021
Q2 | $2.56M | Buy |
38,445
+3,242
| +9% | +$229K | ﹤0.01% | 1339 |
|
|
2021
Q1 | $3.91M | Buy |
35,203
+32,379
| +1,147% | +$4.01M | 0.01% | 980 |
|
|
2020
Q4 | $335K | Hold |
2,824
| – | – | ﹤0.01% | 1535 |
|
|
2020
Q3 | $246K | Sell |
2,824
-167,854
| -98% | -$14.7M | ﹤0.01% | 1558 |
|
|
2020
Q2 | $15.3M | Buy |
170,678
+48,362
| +40% | +$4.88M | 0.03% | 537 |
|
|
2020
Q1 | $12.2M | Sell |
122,316
-13,999
| -10% | -$1.52M | 0.03% | 518 |
|
|
2019
Q4 | $15.7M | Buy |
136,315
+11,837
| +10% | +$1.43M | 0.02% | 569 |
|
|
2019
Q3 | $15.7M | Sell |
124,478
-9,849
| -7% | -$1.25M | 0.03% | 509 |
|
|
2019
Q2 | $16.2M | Buy |
134,327
+22,652
| +20% | +$2.23M | 0.03% | 506 |
|
|
2019
Q1 | $9.77M | Sell |
111,675
-49,633
| -31% | -$4.51M | 0.02% | 625 |
|
|
2018
Q4 | $16.1M | Sell |
161,308
-2,501
| -2% | -$263K | 0.03% | 479 |
|
|
2018
Q3 | $18.8M | Sell |
163,809
-363,769
| -69% | -$37.7M | 0.03% | 498 |
|
|
2018
Q2 | $47.3M | Sell |
527,578
-97,757
| -16% | -$8.26M | 0.08% | 253 |
|
|
2018
Q1 | $45.7M | Sell |
625,335
-51,815
| -8% | -$3.56M | 0.08% | 248 |
|
|
2017
Q4 | $39.3M | Sell |
677,150
-5,921
| -0.9% | -$312K | 0.07% | 283 |
|
|
2017
Q3 | $30.6M | Buy |
683,071
+54,485
| +9% | +$2.26M | 0.06% | 354 |
|
|
2017
Q2 | $24.8M | Buy |
628,586
+19,158
| +3% | +$787K | 0.05% | 393 |
|
|
2017
Q1 | $24.7M | Buy |
609,428
+15,593
| +3% | +$609K | 0.04% | 404 |
|
|
2016
Q4 | $23.9M | Sell |
593,835
-9,943
| -2% | -$375K | 0.05% | 384 |
|
|
2016
Q3 | $21.9M | Sell |
603,778
-610,566
| -50% | -$21M | 0.04% | 386 |
|
|
2016
Q2 | $35.2M | Buy |
1,214,344
+494,483
| +69% | +$14.9M | 0.03% | 413 |
|
|
2016
Q1 | $25.2M | Sell |
719,861
-280,823
| -28% | -$9.07M | 0.05% | 294 |
|
|
2015
Q4 | $32.3M | Buy |
1,000,684
+22,365
| +2% | +$725K | 0.07% | 251 |
|
|
2015
Q3 | $31.6M | Buy |
978,319
+17,910
| +2% | +$674K | 0.07% | 259 |
|
|
2015
Q2 | $39.7M | Buy |
960,409
+4,955
| +0.5% | +$209K | 0.08% | 233 |
|
|
2015
Q1 | $42.9M | Buy |
955,454
+202,244
| +27% | +$8.45M | 0.08% | 236 |
|
|
2014
Q4 | $28.2M | Buy |
753,210
+127,912
| +20% | +$4.69M | 0.06% | 311 |
|
|
2014
Q3 | $21.8M | Buy |
625,298
+46
| +0% | +$1.64K | 0.05% | 356 |
|
|
2014
Q2 | $22.1M | Sell |
625,252
-56,082
| -8% | -$1.87M | 0.05% | 341 |
|
|
2014
Q1 | $22.2M | Sell |
681,334
-155,812
| -19% | -$5.95M | 0.04% | 321 |
|
|
2013
Q4 | $35.3M | Buy |
837,146
+124,232
| +17% | +$5.11M | 0.06% | 222 |
|
|
2013
Q3 | $28.4M | Buy |
712,914
+8,259
| +1% | +$347K | 0.06% | 264 |
|
|
2013
Q2 | $29.1M | Buy |
+704,655
| New | +$28.5M | 0.06% | 237 |
|
Other funds holding HAE
RRAM
Macquarie Group's HAE Position: Q3 2025 in Review
Macquarie Group sold out of Haemonetics (HAE) in Q3 2025, closing a stake of 47,900 shares — an estimated $3.57M sold.
Macquarie Group first reported a position in HAE in Q2 2013 and held it in 49 quarters. The position peaked at $47.3M in Q2 2018. 301 funds tracked by Wall St. Rank hold HAE as of Q3 2025.
- Macquarie Group reported no remaining Haemonetics position as of Q3 2025 after selling out during the quarter.
- Macquarie Group sold 47,900 Haemonetics shares in Q3 2025, an estimated $3.57M.
- Macquarie Group first reported a position in Haemonetics in Q2 2013 and held it in 49 quarters.
- Macquarie Group's Haemonetics position peaked at $47.3M in Q2 2018.
- 301 funds tracked by Wall St. Rank held Haemonetics as of Q3 2025.
Based on Macquarie Group's 13F filing for Q3 2025, filed 13 Nov 2025.